EUVIMEDEUVIMED entdecken
Open Access

Transcriptomic and epigenomic signatures distinguish high‐ and low‐risk endotypes for liver tumor development

Sandra L Grimm, Tia Talley, Rahul K Jangid, Amrit Koirala, Micah B Castillo, Preethi H Gunaratne, Cristian Coarfa, Cheryl L Walker

Environmental and Molecular Mutagenesis · 2024

DOI: 10.1002/em.22639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental and Molecular Mutagenesis, 2024. Verfasst von Sandra L Grimm und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Transcriptome, Liver Neoplasms, Mice, Inbred C57BL. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Diana Helis Henry Medical Research Foundation, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The epigenome is a target for environmental exposures and a potential determinant of inter‐individual differences in response. In genetically identical C57Bl/6 mice exposed from gestation to weaning to the endocrine‐disrupting chemical (EDC) tributyltin (TBT), hepatic tumor development later in life varied across multiple cohorts over time and depending on sex and diet. In one cohort where approximately half of TBT‐exposed male mice developed liver tumors at 10 months (Katz et al. Hepatic tumor formation in adult mice developmentally exposed to organotin, Environmental Health Perspectives , 128 (1), 17010, 2020), transcriptomic (RNA‐seq) and epigenomic (ChIP‐seq) profiling was performed on blood and liver tissue from mice that developed tumors (i.e., “high‐risk”) and equivalently exposed mice did not (i.e., “low‐risk”). Blood transcriptomic signatures separated TBT‐exposed from vehicle controls but did not discriminate between animals that developed tumors versus those that did not. However, uninvolved liver tissue of mice with tumors exhibited transcriptomic and epigenomic signatures distinct from liver tissue of mice without tumors and had many features in common with tumors. These high‐risk transcriptomic and epigenomic features were also found in 10/26 TBT‐exposed mice at 5 months, indicating that this risk signature preceded tumor development. Thus, while early life exposure to TBT exhibits variable penetrance for hepatic tumor development, indicating TBT exposure is not sufficient for liver tumorigenesis, increased risk for hepatic tumor development is linked to epigenomic and transcriptomic reprogramming of the liver induced by this EDC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TranscriptomeLiver NeoplasmsMice, Inbred C57BLAnimalsMiceMaleFemaleTrialkyltin CompoundsEndocrine DisruptorsEpigenomicsLiverEpigenesis, Genetic

Stichwörter der Autor:innen

developmental reprogrammingendocrine disrupting chemicalepigenomeliver tumortranscriptometributyltin

Substanzen

Trialkyltin CompoundstributyltinEndocrine Disruptors

Autor:innen und Institutionen

  • Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, Texas, USA.
  • Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
  • Center for Precision Environmental Health, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Biology and Biochemistry, University of Houston, Houston, Texas, USA.

Förderung

  • NIH HHS
  • Diana Helis Henry Medical Research Foundation
  • NCI NIH HHS
  • NIEHS NIH HHS
  • Cancer Prevention and Research Institute of Texas
  • National Institutes of Health

Zitieren

APA

Grimm, S. L., Talley, T., Jangid, R. K., Koirala, A., Castillo, M. B., Gunaratne, P. H., Coarfa, C., & Walker, C. L. (2024). Transcriptomic and epigenomic signatures distinguish high‐ and low‐risk endotypes for liver tumor development. Environmental and Molecular Mutagenesis. https://doi.org/10.1002/em.22639

Vancouver

Grimm SL, Talley T, Jangid RK, Koirala A, Castillo MB, Gunaratne PH, et al. Transcriptomic and epigenomic signatures distinguish high‐ and low‐risk endotypes for liver tumor development. Environmental and Molecular Mutagenesis. 2024. doi:10.1002/em.22639

BibTeX
@article{Grimm2024,
  author = {Grimm, Sandra L and Talley, Tia and Jangid, Rahul K and Koirala, Amrit and Castillo, Micah B and Gunaratne, Preethi H and Coarfa, Cristian and Walker, Cheryl L},
  title = {Transcriptomic and epigenomic signatures distinguish high‐ and low‐risk endotypes for liver tumor development},
  journal = {Environmental and Molecular Mutagenesis},
  year = {2024},
  doi = {10.1002/em.22639}
}
Kostenlos starten →